Weekly docetaxel (D) plus gemcitabine (G) or vinorelbine (V) in refractory advanced breast cancer (ABC) patients. A parallel dose-finding study

1999 ◽  
Vol 35 ◽  
pp. S325
Author(s):  
G. Frasci ◽  
P. Comella ◽  
A. Apicella ◽  
G. D'Aiuto ◽  
R. Thomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
Weekly Docetaxel ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

2002 ◽  
Vol 13 (4) ◽  
pp. 546-552 ◽  
Author(s):  
M. Venturini ◽  
L. Del Mastro ◽  
O. Garrone ◽  
C. Angiolini ◽  
M. Merlano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
Line Chemotherapy

scholarly journals Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

1999 ◽  
Vol 10 (5) ◽  
pp. 539-546 ◽  
Author(s):  
O. Pagani ◽  
C. Sessa ◽  
G. Martinelli ◽  
D. Crivellari ◽  
A. Buonadonna ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
Line Chemotherapy

963 Exemestane in postmenopausal patients with advanced breast cancer: A dose-finding study

1995 ◽  
Vol 31 ◽  
pp. S200
Author(s):  
N. Zilembo ◽  
C. Noberasco ◽  
A. Martinetti ◽  
L. Mariani ◽  
L. Rimassa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document